Guizhou Cancer Hospital

Guiyang, Guizhou 550000

0 studies enrolling now · 1 studies all time

What they study most

Nasopharyngeal Carcinoma

Studies at this site

• A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma — Running, not enrolling